1. Show article details.

    ZELTIQ Announces Conference Call and Webcast of Fourth Quarter and Full Year 2015 Financial Results to Be Held on February 29, 2016

    Market Wire – 9:00 AM ET 02/12/2016

    02/12/16 -- ZELTIQ® , a medical technology company focused on developing and commercializing products utilizing its proprietary controlled-cooling technology platform, announced today that it plans to release its fourth quarter and full year 2015 financial results on Monday, February 29, 2016 after the market close.

  2. Show article details.

    ZELTIQ to Present at the Leerink Partners 5th Annual Global Healthcare Conference

    Market Wire – 4:01 PM ET 01/28/2016

    01/28/16 -- ZELTIQ® , a medical technology company focused on developing and commercializing products utilizing its proprietary controlled-cooling technology platform, today announced that Mark Foley, President and Chief Executive Officer is scheduled to present at the Leerink Partners 5th Annual Global Healthcare Conference New York City.

  3. Show article details.

    ZELTIQ Added to the S&P SmallCap 600(R) Index

    Market Wire – 4:01 PM ET 01/27/2016

    01/27/16 --  ZELTIQ® , a medical technology company focused on developing and commercializing products utilizing its proprietary controlled-cooling technology platform, today announced that the Company has been selected by S&P Dow Jones Indices to join the S&P SmallCap 600 after the close of trading on January 29, 2016.

  4. Show article details.

    Citizens Financial Group Set to Join the S&P 500; ZELTIQ Aesthetics, RE/MAX to Join S&P SmallCap 600

    PR Newswire – 6:15 PM ET 01/26/2016

    NEW YORK, Jan. 26, 2016  S&P Dow Jones Indices will make the following changes to the S&P 500 and S&P SmallCap 600 indices: Citizens Financial Group (CFG) provides retail and commercial banking products and services. ZELTIQ Aesthetics (ZLTQ) is a medical technology company. RE/MAX Holdings (RMAX) operates as a franchisor of residential and commercial real estate brokerage services.

  5. Show article details.

    ZELTIQ Announces Executive Leadership Addition and Global Commercial Operations Realignment

    Market Wire – 9:01 AM ET 01/12/2016

    01/12/16 -- ZELTIQ® , a medical technology company focused on developing and commercializing products utilizing its proprietary controlled-cooling technology platform, announced today additions to its executive leadership team and realignment of its global commercial operations.

  6. Show article details.

    ZELTIQ Reports Preliminary Fourth Quarter and Full Year 2015 Revenue

    Market Wire – 9:00 AM ET 01/12/2016

    01/12/16 -- ZELTIQ®  ZELTIQ® , a medical technology company focused on developing and commercializing products utilizing its proprietary controlled-cooling technology platform, announced today preliminary unaudited revenue for the fourth quarter and full year 2015.

  7. Show article details.

    ZELTIQ(R) Unveils National CoolSculpting(R) Ad Campaign

    Market Wire – 9:00 AM ET 12/28/2015

    12/28/15 -- ZELTIQ® Aesthetics, Inc. , a medical technology company focused on developing and commercializing products utilizing its proprietary controlled-cooling technology, today announced the launch of its national advertising campaign that encourages consumers to Fear No Mirror® with the CoolSculpting® procedure.

  8. Show article details.

    ZELTIQ to Present at the J.P. Morgan 34th Annual Healthcare Conference

    Market Wire – 4:05 PM ET 12/18/2015

    12/18/15 -- ZELTIQ® , a medical technology company focused on developing and commercializing products utilizing its proprietary controlled-cooling technology platform, today announced that Mark Foley, President and Chief Executive Officer is scheduled to present at the J.P. Morgan 34th Annual Healthcare Conference in San Francisco, CA. This conference will allow institutional investors to meet ...

  9. Show article details.

    Galderma and ZELTIQ Announce U.S. Collaboration in Aesthetics

    PR Newswire – 9:00 AM ET 12/08/2015

    FORT WORTH, Texas and PLEASANTON, Calif.

  10. Show article details.

    ZELTIQ to Present at the Piper Jaffray 27th Annual Healthcare Conference

    Market Wire – 4:01 PM ET 11/24/2015

    11/24/15 -- ZELTIQ® , a medical technology company focused on developing and commercializing products utilizing its proprietary controlled-cooling technology platform, today announced that Mark Foley, President and Chief Executive Officer, is scheduled to present at the Piper Jaffray 27th Annual Healthcare Conference in New York City.

  11. Show article details.

    Zeltiq Announces Third Quarter 2015 Financial Results

    Market Wire – 4:01 PM ET 10/27/2015

    10/27/15 -- ZELTIQ®, a medical technology company focused on developing and commercializing products utilizing its proprietary controlled-cooling technology platform, today announced financial results for the third quarter 2015.

  12. Show article details.

    ZELTIQ Announces Location and Agenda for 2015 Investor Day

    Market Wire – 4:05 PM ET 10/21/2015

    10/21/15 -- ZELTIQ®, a medical technology company focused on developing and commercializing products utilizing its proprietary controlled-cooling technology platform, today announced the location and agenda for its 2015 investor and analyst day. The event will focus on the Company's growth initiatives, R&D pipeline, and financial outlook.

  13. Show article details.

    ZELTIQ(R) Aesthetics Showcasing Its CoolMini(TM) Applicator

    Market Wire – 9:00 AM ET 10/15/2015

    10/15/15 -- ZELTIQ® Aesthetics, Inc., a medical technology company focused on developing and commercializing products utilizing its proprietary controlled-cooling technology platform, today announced it is showcasing the new CoolMini™ applicator at the American Society of Dermatologic Surgery annual meeting in Chicago, October 15-18, and at Plastic Surgery The Meeting in Boston, October 16-20.

  14. Show article details.

    ZELTIQ Announces Conference Call and Webcast of Third Quarter 2015 Financial Results to Be Held on October 27, 2015

    Market Wire – 4:05 PM ET 10/13/2015

    10/13/15 -- ZELTIQ®, a medical technology company focused on developing and commercializing products utilizing its proprietary controlled-cooling technology platform, announced today that it plans to release its third quarter 2015 financial results on Tuesday, October 27, 2015 after the market close.

  15. Show article details.

    ZELTIQ(R) Receives FDA Clearance to Treat Submental Fat With Coolsculpting(R) Procedure

    Market Wire – 8:00 AM ET 09/23/2015

    09/23/15 -- ZELTIQ® Aesthetics, Inc., a medical technology company focused on developing and commercializing products utilizing its proprietary controlled-cooling technology, today announced that it received an expanded clearance from the U.S. Food and Drug Administration paving the way for introduction of the new, CoolMini™ applicator, which is designed to treat smaller pockets of fat, includ...

Page:

Today's and Upcoming Events

  • Feb
    29

    ZLTQ to announce Q4 earnings After Market (Confirmed)

  • Feb
    29

    ZLTQ Earnings Conference Call at 4:30 PM Listen

Past Events (last 90 days)

No events in the past 90 days

Data provided by Wall Street Horizon, Inc. © 2016

Technical Events

Technical Analysis

PROVIDED BY TRADING CENTRAL
As with all your investments through Fidelity, you must make your own determination whether an investment is appropriate for you. Fidelity is not recommending or endorsing this security by making it available to customers. You should conduct research and perform a thorough investigation as to the characteristics of any securities you intend to purchase. Before investing, you should read the prospectus, offering circular, indenture, or similar document carefully for a full description of the product, including its features and risks, to determine whether it is an appropriate investment for your investment objectives, risk tolerance, financial situation and other individual factors, and be sure to re-evaluate those factors on a periodic basis.

Performance data shown represents past performance, which is no guarantee of future results. Current performance may be higher or lower than the performance data quoted. Yield and return will vary, therefore, you may have a gain or loss when you sell your shares.


Stock markets are volatile and can decline significantly in response to adverse issuer, political, regulatory, market, or economic developments. Growth stocks can be more volatile than other types of stocks. Value stocks can continue to be undervalued by the market for long periods of time. Foreign securities are subject to interest-rate, currency-exchange-rate, economic, and political risks, all of which are magnified in emerging markets. Illiquidity is an inherent risk associated with investing in real estate and REITs. There is no guarantee the issuer of a REIT will maintain the secondary market for its shares and redemptions may be at a price which is more or less than the original price paid. Closed-end funds can trade at a discount to their NAV. Shareholders of Master Limited Partnerships may be treated as partners for tax purposes. Partnerships issue a Schedule K-1 (Form 1065) rather than a Form 1099 form for tax purposes. It lists the partner's share of income, deductions, credits, etc. Speak with your tax advisor to determine how this may affect you. A royalty trust is a type of corporation, mostly in the United States or Canada, usually involved in oil and gas production or mining. Royalty trusts may have special tax treatment, so you should consult a tax advisor on the potential tax consequences of investing in them.

News, commentary and events are from third-party sources unaffiliated with Fidelity. Fidelity does not endorse or adopt their content. Fidelity makes no guarantees that information supplied is accurate, complete, or timely, and does not provide any warranties regarding results obtained from their use.

Any data, charts and other information provided on this page are intended for research purposes to help self-directed investors evaluate many types of securities including, but not limited to common stocks, American Depository Receipts, Master Limited Partnerships, real estate investment trusts. traditional preferred stock, trust preferred securities, third-party trust certificates, convertible securities, mandatory convertible securities and other exchange-traded equity and/or debt securities. Criteria and inputs entered, including the choice to make security comparisons, are at the sole discretion of the user and are solely for the convenience of the user. Analyst opinions, ratings and reports are provided by third-parties unaffiliated with Fidelity. All information supplied or obtained from this page is for informational purposes only and should not be considered investment advice or guidance, an offer of or a solicitation of an offer to buy or sell a security, or a recommendation or endorsement by Fidelity of any security or investment strategy. Fidelity does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities. Fidelity makes no guarantees that information supplied is accurate, complete, or timely, and does not provide any warranties regarding results obtained from its use.